WEMADE
Wemade’s MMORPG MIR M: Vanguard and Vagabond (hereinafter "MIR M") is hosting its first Hidden Valley Capture on March 8th at 10 pm.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005556/en/
MIR M Hidden Valley Capture Update (Graphic: Wemade)
Hidden Valley Capture is clan war content where clans compete to capture a "Hidden Valley," which is the source of the core resource, "Darksteel." Held every Wednesday at 10 pm for one hour on the fourth floor of Bicheon, Snake Pit, and Phantasia Hidden Valley, this content will only be available in certain Servers according to the results of Governance.
Governance votes are held for each World for the selection of Servers in which Hidden Valley Capture will be made available. Users can vote on the Server they want using the Governance Token, "DOGMA." Of the 8 Servers in each World, Hidden Valley Capture will be made available in the 4 Servers that received the most votes in Governance.
Once Hidden Valley Capture begins, ownership of a Hidden Valley is transferred to the clan of the clan member that dealt the final blow to the Capture Stone, which is on the fourth floor of each Hidden Valley. The clan with ownership of the Capture Stone at the end of the battle is declared the final winner, and is given ownership of the Hidden Valley.
The winning clan is given the great power to manage the Darksteel Storage, which is where all Darksteel Tax for that Hidden Valley are collected. Every day, 15% of the total Darksteel mined in the Hidden Valley is stored in the Storage as Darksteel Tax. The Taxes from the 4 Servers in which Hidden Valley Capture is not available will be allocated to the top 4 Servers based on Governance rankings. The Clan Master can use accumulated Darksteel as clan resources or allocate it to individual users.
MIR M will be adding more Governance contents to increase the utility of the Governance Token, "DOGMA."
Also, a new Check-in event will be held until March 20th. All users can obtain various items such as "Dragonsoul Mystic Steel Piece," "Growth Draught," "Enhancement Stone," and more.
Moreover, users over level 30 can enjoy the event dungeon "Nachal's Secret Cave" every day for two hours. "Nachal's Token" items obtained from the event dungeon can be used to craft various "Summoning Ticket" and "Skill Tome Chest" items at Yoyo’s Crafting Station.
More information on MIR M can be found on the official website.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005556/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune Therapeutics13.5.2025 14:05:00 CEST | Press release
Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics, a pioneering epigenetic editing company. This honor celebrates the teams’ partnership and sets a benchmark for CRO–biotech partnerships. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513574699/en/ Novotech is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics. The CRO Partnership of the Year award honors outstanding collaboration between a CRO and a pharmaceutical or biotech company that has advanced clinical programs through strong alignment and shared goals. Sarah Anderson, Director of Therapeutic Strategy, and Steve Roan, Associate Director of Business Development, acce
KnowBe4 Report Reveals Security Training Reduces Global Phishing Click Rates by 86%13.5.2025 14:00:00 CEST | Press release
KnowBe4’s 2025 Phishing by Industry Benchmarking Report shows a drop in the global Phish-prone™ Percentage (PPP) to 4.1% after 12 months of security training KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, today launched its “Phishing by Industry Benchmarking Report 2025” which measures an organization’s Phish-prone™ Percentage (PPP) — the percentage of employees likely to fall for social engineering or phishing attacks, indicating the organization’s overall susceptibility to phishing threats. This year’s report found a global average baseline PPP of 33.1%, meaning a third of employees interact with phishing simulations before taking part in best-practice security awareness training (SAT). The data underscores the significant impact of SAT in mitigating risk. The rapid decline in the global PPP following the implementation of training — falling by 40% in just three months and by a total of 86% after 12 months — demonstrates that
Armis Announces New Global Technology Integration Partners to Bolster Organizations’ Cyber Resilience13.5.2025 14:00:00 CEST | Press release
Strategic partnerships enhance and optimize technology stacks for joint customers Armis, the cyber exposure management & security company, today announced that it has added 10 global technology integration partners over the past quarter. These integrations increase the functionality and efficiency of organizations’ existing technology stacks with added benefits from Armis’ platform and solutions. “Relying on siloed security solutions is no longer enough to gain a comprehensive, real-time understanding of an organization’s attack surface,” said Nadir Izrael, CTO and Co-Founder at Armis. “Integrating Armis’ best-in-class platform with other leading vendors’ offerings empowers businesses to consolidate their technology stacks. By driving greater value in their security investments, organizations can ensure their entire attack surface is continuously defended and managed.” New Armis global technology integration partners include AnzenOT, Brinqa, ColorTokens, EasyVista, SaltyCloud, Salvador
Kyriba Unveils Agentic AI TAI to Transform Finance with Security, Compliance & Trust13.5.2025 13:35:00 CEST | Press release
Liquidity Performance Leader to Fill ‘Trust Gap’, Empower CFOs to Outperform Volatility Kyriba, a global leader in liquidity performance, today introduced its agentic AI solution, TAI – a significant advancement in the safe, compliant use of generative AI in finance operations to improve productivity and efficiency amid continued economic uncertainty. Powered by Kyriba's embedded Large Language Model (LLM) and over 20 years of unmatched global liquidity data, TAI simplifies complex workflows, identifies risks with predictive analytics, and enhances data-driven decision-making across treasury, payments, risk management and working capital. Poised to transform finance and treasury operations without relying on third-party LLM integrations, TAI is a key component of Kyriba’s Trusted AI portfolio. This platform-wide approach prioritizes industry-leading data privacy while empowering enterprise leaders to make faster, smarter decisions with human judgement and responsibility at the center.
BeiGene to Present at the RBC Capital Markets Global Healthcare Conference13.5.2025 12:01:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will participate in the RBC Capital Markets Global Healthcare Conference on May 20, 2025, with a fireside chat at 10 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at http://ir.beigene.com/, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available for 1 year following the event. About BeiGene BeiGene, which will change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom